Skip to main content

Muscular Skeletal Tumors

  • Chapter
PET-CT
  • 899 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bredella MA, Caputo GR, Steinbach LS. Value of FDG positron emission tomography in conjunction with MR imaging for evaluating therapy response in patients with musculoskeletal sarcomas. Am J Roentgenol 2002;179:1145–1150.

    Google Scholar 

  2. Dimitrakopoulou-Strauss A, Strauss LG, Schwarzbach M, et al. Dynamic PET 18F-FDG studies in patients with primary and recurrent soft-tissue sarcomas: Impact on diagnosis and correlation with grading. J Nucl Med 2001;42:713–720.

    PubMed  Google Scholar 

  3. Franzius C, Sciuk J, Brinkschmidt C, Jurgens H, Schober O. Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis. Clin Nucl Med 2000;25:874–881.

    Article  PubMed  Google Scholar 

  4. Franzius C, Bielack S, Flege S, Sciuk J, Jurgens H, Schober O. Prognostic significance of 18F-FDG and 99mTc-methylene diphosphonate uptake in primary osteosarcoma. J Nucl Med 2002;43:1012–1017.

    PubMed  Google Scholar 

  5. Ioannidis JPA, Lau J. 18F-FDG PET for the diagnosis and grading of soft-tissue sarcoma: a meta-analysis. J Nucl Med 2003;44:717–724.

    PubMed  Google Scholar 

  6. Jones DN, McCowage GB, Sostman HD, et al. Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET. J Nucl Med. 1996;37(9):1438–1444.

    PubMed  Google Scholar 

  7. Messa C, Landoni C, Pozzato C, Fazio F. Is there a role for FDG PET in the diagnosis of musculoskeletal neoplasms? J Nucl Med 2000;41(10):1702–1703.

    PubMed  Google Scholar 

  8. Schulte M, Brech-Krauss D, Heymer B, et al. Grading of tumors and tumor like lesions of bone: Evaluation by FDG PET. J Nucl Med 2000;41:1695–1701.

    PubMed  Google Scholar 

  9. Schwarzbach M, Willeke F, Dimitrakopoulou-Strauss A, et al. Functional imaging and detection of local recurrence in soft tissue sarcomas by positron emission tomography Anticancer Res 1999;19(2B):1343–1349.

    PubMed  Google Scholar 

  10. Brenner W, Bohuslavizki KH, Eary JF. PET imaging of osteosarcoma. J Nucl Med 2003;44:930–942.

    PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Ramanna, L., Gamie, S. (2005). Muscular Skeletal Tumors. In: Conti, P.S., Cham, D.K. (eds) PET-CT. Springer, New York, NY. https://doi.org/10.1007/0-387-27044-2_21

Download citation

  • DOI: https://doi.org/10.1007/0-387-27044-2_21

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-20858-9

  • Online ISBN: 978-0-387-27044-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics